RAPH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.360600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.454600E-01
Normal-vs-Stage2
6.936200E-01
Normal-vs-Stage3
4.824800E-01
Normal-vs-Stage4
1.205770E-01
Stage1-vs-Stage2
7.717800E-01
Stage1-vs-Stage3
2.326200E-01
Stage1-vs-Stage4
5.339800E-02
Stage2-vs-Stage3
1.742180E-01
Stage2-vs-Stage4
1.090150E-01
Stage3-vs-Stage4
1.316360E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.769600E-01
Normal-vs-AfricanAmerican
7.572600E-01
Normal-vs-Asian
6.051200E-01
Caucasian-vs-AfricanAmerican
8.316200E-01
Caucasian-vs-Asian
4.287600E-01
AfricanAmerican-vs-Asian
7.969600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.007000E-01
Normal-vs-Female
7.933200E-01
Male-vs-Female
5.239000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.901200E-01
Normal-vs-Age(41-60Yrs)
4.391400E-01
Normal-vs-Age(61-80Yrs)
8.579000E-01
Normal-vs-Age(81-100Yrs)
7.786400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.356200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.161600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.461200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.910200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.144500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.100000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.648000E-01
Normal-vs-Daily Drinker
9.104800E-01
Normal-vs-Weekly Drinker
6.813000E-01
Normal-vs-Occasional Drinker
4.953000E-01
Normal-vs-Social Drinker
8.047000E-01
Non Drinker-vs-Daily Drinker
8.728600E-01
Non Drinker-vs-Weekly Drinker
3.586600E-01
Non Drinker-vs-Occasional Drinker
8.782200E-02
Non Drinker-vs-Social Drinker
5.322000E-01
Daily Drinker-vs-Weekly Drinker
2.770800E-01
Daily Drinker-vs-Occasional Drinker
9.547700E-02
Daily Drinker-vs-Social Drinker
4.853800E-01
Weekly Drinker-vs-Occasional Drinker
7.653600E-01
Weekly Drinker-vs-Social Drinker
6.647400E-01
Occasional Drinker-vs-Social Drinker
3.911800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.855700E-02
Normal-vs-Grade 2
2.420500E-02
Normal-vs-Grade 3
1.248170E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.538300E-03
Grade 1-vs-Grade 3
8.722500E-03
Grade 1-vs-Grade 4
7.855700E-02
Grade 2-vs-Grade 3
9.360200E-01
Grade 2-vs-Grade 4
2.420500E-02
Grade 3-vs-Grade 4
1.248170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.483200E-01
Normal-vs-NonDiabetic
7.357800E-01
Diabetic-vs-NonDiabetic
4.429400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.713600E-01
Normal-vs-NoPancreatitis
8.029200E-01
Pancreatitis-vs-NoPancreatitis
5.894200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.331800E-01
Normal-vs-N1
6.948200E-01
N0-vs-N1
4.570800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.931600E-01
Normal-vs-TP53-NonMutant
9.069600E-01
TP53-Mutant-vs-TP53-NonMutant
2.354300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
